Search results
Results from the WOW.Com Content Network
NHS England said people will be offered the next-generation bivalent vaccine where appropriate and subject to sufficient supply. NHS to roll out variant-busting COVID booster jab from September ...
Big news in health: The Food and Drug Administration has approved new COVID-19 vaccines from Pfizer and Moderna. The updated vaccines are targeted toward the KP.2 strain of SARS-CoV-2, the virus ...
Everyone over the age of 50 will be offered a Covid-19 booster and flu jab this autumn, the UK Health Security Agency (UKHSA) has announced. This is a change from previous guidance from the Joint ...
By this point, more than 26 million people had received their first dose of a COVID-19 Vaccine. [72] On 7 April 2021, Elle Taylor, 24, became the first person in the UK (outside trials) to receive the Moderna vaccine. The vaccine was administered on Miss Taylor, an unpaid carer from Ammanford, at Glangwili General Hospital, Carmarthen. [73]
Immunisation against infectious disease, popularly known as The Green Book, provides information on vaccines for vaccine-preventable diseases. It acts as a guide to the UK's vaccination schedule for health professionals and health departments that give vaccines in the United Kingdom. The first two editions were published in 1992 and 1996.
The NHS Health Check is a preventive healthcare programme in the United Kingdom offered by National Health Service. The programme invites adults aged between 40 and 74 in England for a health check-up every five years to screen for key conditions including heart disease , diabetes , kidney disease , and stroke . [ 1 ]
A decision on whether the over-50s will need a third Covid-19 jab is to be set out by vaccination experts in the next few weeks. If the programme is given the green light, it is expected that all ...
The Moderna COVID‑19 vaccine, sold under the brand name Spikevax, is a COVID-19 vaccine developed by the American company Moderna, the United States National Institute of Allergy and Infectious Diseases (NIAID), and the Biomedical Advanced Research and Development Authority (BARDA).